FWM
ATHE

Focused Wealth Management’s Alterity Therapeutics ATHE Stock Holding History

Focused Wealth Management’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3
Closed – – 677
2015
Q2 		$0 Hold
3
– – ﹤0.01% 660
2015
Q1 		$0 Hold
3
– – ﹤0.01% 672
2014
Q4 		$0 Hold
3
– – ﹤0.01% 660
2014
Q3 		$0 Hold
3
– – ﹤0.01% 685
2014
Q2 		$0 Hold
3
– – ﹤0.01% 665
2014
Q1 		$0 Buy
+3
New +$1.66K ﹤0.01% 627

Other funds holding ATHE

GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CAM
Columbia Asset Management Ann Arbor, Michigan $525M AUM 21.5% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Focused Wealth Management's ATHE Position: Q3 2015 in Review

Focused Wealth Management sold out of Alterity Therapeutics (ATHE) in Q3 2015, closing a stake of 3 shares.

Focused Wealth Management first reported a position in ATHE in Q1 2014 and held it in 6 quarters. The position peaked at $0 in Q2 2015. 20 funds tracked by Wall St. Rank hold ATHE as of Q3 2015.

  • Focused Wealth Management reported no remaining Alterity Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Focused Wealth Management sold 3 Alterity Therapeutics shares in Q3 2015.
  • Focused Wealth Management first reported a position in Alterity Therapeutics in Q1 2014 and held it in 6 quarters.
  • Focused Wealth Management's Alterity Therapeutics position peaked at $0 in Q2 2015.
  • 20 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2015.

Based on Focused Wealth Management's 13F filing for Q3 2015, filed 10 Nov 2015.